Zenotech Laboratories

Zenotech Laboratories Operating Cash Flow

The Operating Cash Flow of Zenotech Laboratories (532039.BO) as of Oct 29, 2026 is 102.05 M INR. In the previous year, Operating Cash Flow was 94.88 M INR — a change of 7.55% (higher).

Operating Cash Flow

102.05 MINR

YoY

7.55%

Last updated:

Operating Cash Flow of Zenotech Laboratories is 2026 102.05 M INR. Operating Cash Flow of Zenotech Laboratories was 2025 94.88 M INR. It decreases by 7.55% higher compared to the previous year.

The Zenotech Laboratories Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
-140.43 M INR
Jan 1, 2020
113.79 M INR
Jan 1, 2021
57.41 M INR
Jan 1, 2022
176.67 M INR
Jan 1, 2023
206.64 M INR
Jan 1, 2024
118.23 M INR
Jan 1, 2025
94.88 M INR
Jan 1, 2026
102.05 M INR
The Zenotech Laboratories Operating Cash Flow history
YEAROperating Cash FlowYoY
102.05 MINR+7.55%
94.88 MINR-19.74%
118.23 MINR-42.79%
206.64 MINR+16.96%
176.67 MINR+207.74%
57.41 MINR-49.55%
113.79 MINR-181.03%
-140.43 MINR-13.59%
-162.51 MINR-1,092.93%
16.37 MINR-134.10%
-47.99 MINR-37.80%
-77.16 MINR-53.24%
-164.99 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Operating Cash Flow of Zenotech Laboratories is 102.05 M INR in 2026.

Operating Cash Flow of Zenotech Laboratories changed from 94.88 M INR to 102.05 M INR, representing a 7.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories